期刊文献+

磷酸化AKT在卵巢癌中表达的临床意义及其与新癌基因REDD1表达的相关性研究 被引量:6

The clinical significance of the phosphorylated AKT expression and its correlation with new oncogene REDD1 expression in ovarian cancer
下载PDF
导出
摘要 目的研究磷酸化蛋白激酶B(p-AKT)在卵巢癌中的表达与卵巢癌患者的临床病理因子以及生存预后之间的关系,并分析p-AKT表达与发育及DNA损伤反应调节基因1(REDD1)表达的相关性。方法收集卵巢癌组织标本95例,交界性肿瘤23例,正常卵巢表面上皮和输卵管组织18例。采用免疫组织化学En Vision两步法检测p-AKT和REDD1的表达,分析p-AKT表达与患者临床病理因子(分期、分级、化疗反应、无瘤生存期和总体生存期等)的关系,并分析p-AKT和REDD1表达的相关性。结果 1卵巢癌组织中p-AKT表达率为55.8%(53/95),均高于卵巢正常上皮组织(16.7%)和卵巢交界性肿瘤组织(13.0%)(P<0.05)。2 p-AKT蛋白的表达与卵巢癌的分化程度低、临床晚分期相关,且在浆液性癌中的高表达率高于其他组织学类型,但与有无腹水形成无显著相关性(P>0.05)。3 p-AKT在化疗无效组患者中的表达高于有效组(P<0.05)。4 pAKT蛋白高表达患者的总体生存期和无瘤生存期低于低表达者(P<0.05)。5卵巢癌中p-AKT的表达和REDD1的表达呈正相关性(C=0.626,P<0.05)。结论 p-AKT是影响卵巢癌患者化疗反应以及预后的一个重要因素;AKT可能被持续性高表达的REDD1激活,从而促进细胞增殖,参与卵巢癌的病理发生。 Objective To investigate clinical significance of the expression of phosphorylated protein kinase B (p-AKT) in ovarian carcinomas,and to evaluate its correlation with the expression of new oncogene REDD1.Methods 18 cases of normal ovarian epithelial tissues and fallopian tube tissues,23 cases of borderline tumor and 95 cases of ovarian carcinoma were collected.The expression of p-AKT and REDD1 were detected with immunohistochemical staining method (EnVision two step methods).The correlations between the expression of p-AKT and the clinical pathological factors of ovarian cancer patients,including grade,stage,chemotherapy response,disease-free survival time and overall survival time were analyzed.The association of p-AKT and REDD1 expression was also analyzed.Results Expression of p-AKT was found in 55.8% of the samples,which was significantly higher than those in the normal epithelial tissues (16.7%) (P < 0.05) and borderline tumors (13.0%) (P < 0.05).Chisquare test suggested that high expression of p-AKT was significantly associated with serous carcinoma (P < 0.05),low degree of differentiation (P < 0.05),late clinical stage (P < 0.05),and chemotherapy resistant (P < 0.05),but there was no significant correlation with the presence of ascites (P > 0.05).High percentage of cells expressing p-AKT was associated with a shorter overall survival time (P < 0.05) and disease free survival time (P < 0.05) by Log rank test.Positive correlation was found between p-AKT and REDD1 (C =0.626,P < 0.05).Conclusion The overexpression of p-AKT had a significant negative impact on the prognostic of ovarian cancer patients.Sustained overexpression of REDD1 leads to AKT activation involved in cancer cells proliferation,leading to the occurrence of ovarian cancer.
出处 《安徽医科大学学报》 CAS 北大核心 2014年第12期1766-1770,共5页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81160316 81260104) 新疆生产建设兵团重点领域科技攻关(编号:2011BA038) 国家人力资源和社会保障部-留学回国人员科技活动项目(编号:2010LX004) 优秀青年科技人才培养计划(编号:2013ZRKXYQ-YD18)
关键词 卵巢癌 蛋白激酶B 发育及DNA损伤反应调节基因1 免疫组织化学 ovarian neoplasms protein kinase B regulated in DNA damage and development 1 immunohistochemistry
  • 相关文献

参考文献16

  • 1De Marco C, Rinaldo N, Bruni P, et al. Multiple genetic altera- tions within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma [ J]. PLoS One, 2013,8 ( 2 ) : e55362.
  • 2Chang B, Liu G, Yang G, et al. REDD1 is required for Ras-me- diated transformation of human ovarian epithelial cells [ J ]. Cell Cycle,2009,8(5 ) :780 -6.
  • 3Jin H O, Hong S E, Kim J H, et al. Sustained overexpression of Reddl leads to Akt activation involved in cell survival[ J ]. Cancer ltt 2013,336(2) : 319 -24.
  • 4Malpica A, Deavers M T, Lu K, et al. Grading ovarian serous car- cinoma using a two-tier system[ J ]. Am J Surg Pathol, 2004,28(4) :496 -504.
  • 5Rustin G J, Nelstrop A E, Crawford M, et al. Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125[J]. J Clin Oncol, 1997,15( 1 ) :172 - 6.
  • 6Shtilbans V, Wu M, Burstein D E. Current overview of the role of Akt in cancer studies via applied inmmnohistochemistry [ J ]. Ann Diagn Patho1,2008,12 (2) : 153 - 60.
  • 7Shukla S, MaelennanG T, Hartman D J, et al, Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion [J]. Int J Cancer,2007,121 (7) : 1424 -32.
  • 8Murakami D, Tsujitani S, Osaki T, et al. Expression of phosphoryl- ated Akt (pAkt) in gastric carcinoma predicts prognosis and effi- cacy of chemotherapy[ J ]. Gastric Cancer,2007,10( 1 ) :45 - 51.
  • 9魏欣,吕庆杰,孙寒雪,齐亚飞,王劲欧,曹程程.上皮性卵巢癌中磷酸化蛋白激酶B和磷酸化糖原合成酶激酶-3β及β-catenin蛋白的表达及意义[J].中华病理学杂志,2012,41(2):86-90. 被引量:9
  • 10Peng D J, Wang J, Zhou J Y. Role of the AklfmTOR survival pathway in cisplatin resistance in ovarian cancer cells [ J 1. Bio- chem Biophys Res Commun,2010,394 (3) :600 -5.

二级参考文献21

  • 1于宝华,周晓燕.PI3K/Akt/mTOR的信号传导通路在恶性肿瘤中的研究进展[J].中华病理学杂志,2005,34(10):674-676. 被引量:20
  • 2曹漫明,张积仁,汪森明,胡喜钢,胡利娟.卵巢癌顺铂耐药细胞中DNA转录与修复相关基因的表达[J].第一军医大学学报,2005,25(12):1478-1481. 被引量:5
  • 3汪华,邓长生,余峰.糖原合成酶激酶-3β与胃癌细胞增殖关系的研究[J].数理医药学杂志,2006,19(5):509-510. 被引量:8
  • 4王智峰,张珊珊,刘玉兰,叶颖江,王杉.Wnt1和β-catenin在结直肠腺瘤中的表达及其意义[J].中华普通外科杂志,2007,22(1):21-24. 被引量:3
  • 5Malik SN,Brattain M,Ghosh PM,et al.Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.Clin Cancer Res,2002,8 (4):1168-1171.
  • 6Shtilbans V,Wu M,Burstein DE.Current overview of the role of Akt in cancer studies via applied immunohistochemistry. Ann Diagn Pathol,2008,12(2):153-160.
  • 7Liang J,Slingerland JM.Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle,2003,2(4):339-345.
  • 8Farago M,Dominguez I,Landesman-Bollag E,et al. Kinaseinactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Res,2005,65 (13):5792-5801.
  • 9Cai G,Wang J,Xin X,et al. Phosphorylation of glycogen synthase kinase-3 beta at serine 9 confers cisplatin resistance in ovarian cancer cells.Int J Oncol,2007,31 (3):657-662.
  • 10Xu X,Sun PL,Li JZ,et al.Aberrant Wntl/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery.J Thorac Oncol,2011,6(4):716-724.

共引文献8

同被引文献51

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部